Bristol-Myers Reports Higher Sales but Another Lung-Cancer Setback

Bristol-Myers Squibb said its fourth-quarter revenue rose on sales of key drugs, but it suffered another setback entering the market to treat newly diagnosed lung-cancer patients.

from WSJ.com: US Business https://on.wsj.com/2Sc5ECw
via IFTTT